Cargando…
Current and Future Applications of Toxicogenomics: Results Summary of a Survey from the HESI Genomics State of Science Subcommittee
BACKGROUND: In spite of the application of toxicogenomic (TGx) data to the field of toxicology for the past 10 years, the broad implementation and full impact of TGx for chemical and drug evaluation to improve decision making within organizations and by policy makers has not been achieved. OBJECTIVE...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
National Institute of Environmental Health Sciences
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920921/ https://www.ncbi.nlm.nih.gov/pubmed/20100679 http://dx.doi.org/10.1289/ehp.0901501 |
_version_ | 1782185333693087744 |
---|---|
author | Pettit, Syril des Etages, Shelley Ann Mylecraine, Louis Snyder, Ronald Fostel, Jennifer Dunn, Robert T. Haymes, Kenneth Duval, Manuel Stevens, James Afshari, Cynthia Vickers, Alison |
author_facet | Pettit, Syril des Etages, Shelley Ann Mylecraine, Louis Snyder, Ronald Fostel, Jennifer Dunn, Robert T. Haymes, Kenneth Duval, Manuel Stevens, James Afshari, Cynthia Vickers, Alison |
author_sort | Pettit, Syril |
collection | PubMed |
description | BACKGROUND: In spite of the application of toxicogenomic (TGx) data to the field of toxicology for the past 10 years, the broad implementation and full impact of TGx for chemical and drug evaluation to improve decision making within organizations and by policy makers has not been achieved. OBJECTIVES: The goal of the Health and Environmental Sciences Institute (HESI) Committee on the Application of Genomics to Mechanism-based Risk Assessment was to construct and summarize a multisector survey, addressing key issues and perspectives on the current and future practical uses and challenges of implementing TGx data to facilitate discussions for decision making within organizations and by policy makers. METHODS: An online survey to probe the current status and future challenges facing the field of TGx for drug and chemical evaluation in experimental and nonclinical models was taken by scientists and scientific decision/policy makers actively engaged in the field of TGx within industrial, academic, and regulatory sectors of the United States, Europe, and Japan. For this survey, TGx refers specifically to the analysis of gene expression responses to evaluate xenobiotic exposure in experimental and preclinical models. RESULTS: The survey results are summarized from questions covering broad areas including technology used, organizational capacity and resource allocation, experimental approaches, data storage and exchange, perceptions of benefits and hurdles, and future expectations. CONCLUSIONS: The survey findings provide valuable information on the current state of the science of TGx applications and identify key areas in which TGx will have an impact as well as the key hurdles in applying TGx data to address issues. The findings serve as a public resource to facilitate discussions on the focus of future TGx efforts to ensure that a maximal benefit can be obtained from toxicogenomic studies. |
format | Text |
id | pubmed-2920921 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | National Institute of Environmental Health Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-29209212010-08-13 Current and Future Applications of Toxicogenomics: Results Summary of a Survey from the HESI Genomics State of Science Subcommittee Pettit, Syril des Etages, Shelley Ann Mylecraine, Louis Snyder, Ronald Fostel, Jennifer Dunn, Robert T. Haymes, Kenneth Duval, Manuel Stevens, James Afshari, Cynthia Vickers, Alison Environ Health Perspect Research BACKGROUND: In spite of the application of toxicogenomic (TGx) data to the field of toxicology for the past 10 years, the broad implementation and full impact of TGx for chemical and drug evaluation to improve decision making within organizations and by policy makers has not been achieved. OBJECTIVES: The goal of the Health and Environmental Sciences Institute (HESI) Committee on the Application of Genomics to Mechanism-based Risk Assessment was to construct and summarize a multisector survey, addressing key issues and perspectives on the current and future practical uses and challenges of implementing TGx data to facilitate discussions for decision making within organizations and by policy makers. METHODS: An online survey to probe the current status and future challenges facing the field of TGx for drug and chemical evaluation in experimental and nonclinical models was taken by scientists and scientific decision/policy makers actively engaged in the field of TGx within industrial, academic, and regulatory sectors of the United States, Europe, and Japan. For this survey, TGx refers specifically to the analysis of gene expression responses to evaluate xenobiotic exposure in experimental and preclinical models. RESULTS: The survey results are summarized from questions covering broad areas including technology used, organizational capacity and resource allocation, experimental approaches, data storage and exchange, perceptions of benefits and hurdles, and future expectations. CONCLUSIONS: The survey findings provide valuable information on the current state of the science of TGx applications and identify key areas in which TGx will have an impact as well as the key hurdles in applying TGx data to address issues. The findings serve as a public resource to facilitate discussions on the focus of future TGx efforts to ensure that a maximal benefit can be obtained from toxicogenomic studies. National Institute of Environmental Health Sciences 2010-07 2010-01-25 /pmc/articles/PMC2920921/ /pubmed/20100679 http://dx.doi.org/10.1289/ehp.0901501 Text en http://creativecommons.org/publicdomain/mark/1.0/ Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged (for example, ?Reproduced with permission from Environmental Health Perspectives?); pertinent reference information should be provided for the article from which the material was reproduced. Articles from EHP, especially the News section, may contain photographs or illustrations copyrighted by other commercial organizations or individuals that may not be used without obtaining prior approval from the holder of the copyright. |
spellingShingle | Research Pettit, Syril des Etages, Shelley Ann Mylecraine, Louis Snyder, Ronald Fostel, Jennifer Dunn, Robert T. Haymes, Kenneth Duval, Manuel Stevens, James Afshari, Cynthia Vickers, Alison Current and Future Applications of Toxicogenomics: Results Summary of a Survey from the HESI Genomics State of Science Subcommittee |
title | Current and Future Applications of Toxicogenomics: Results Summary of a Survey from the HESI Genomics State of Science Subcommittee |
title_full | Current and Future Applications of Toxicogenomics: Results Summary of a Survey from the HESI Genomics State of Science Subcommittee |
title_fullStr | Current and Future Applications of Toxicogenomics: Results Summary of a Survey from the HESI Genomics State of Science Subcommittee |
title_full_unstemmed | Current and Future Applications of Toxicogenomics: Results Summary of a Survey from the HESI Genomics State of Science Subcommittee |
title_short | Current and Future Applications of Toxicogenomics: Results Summary of a Survey from the HESI Genomics State of Science Subcommittee |
title_sort | current and future applications of toxicogenomics: results summary of a survey from the hesi genomics state of science subcommittee |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920921/ https://www.ncbi.nlm.nih.gov/pubmed/20100679 http://dx.doi.org/10.1289/ehp.0901501 |
work_keys_str_mv | AT pettitsyril currentandfutureapplicationsoftoxicogenomicsresultssummaryofasurveyfromthehesigenomicsstateofsciencesubcommittee AT desetagesshelleyann currentandfutureapplicationsoftoxicogenomicsresultssummaryofasurveyfromthehesigenomicsstateofsciencesubcommittee AT mylecrainelouis currentandfutureapplicationsoftoxicogenomicsresultssummaryofasurveyfromthehesigenomicsstateofsciencesubcommittee AT snyderronald currentandfutureapplicationsoftoxicogenomicsresultssummaryofasurveyfromthehesigenomicsstateofsciencesubcommittee AT fosteljennifer currentandfutureapplicationsoftoxicogenomicsresultssummaryofasurveyfromthehesigenomicsstateofsciencesubcommittee AT dunnrobertt currentandfutureapplicationsoftoxicogenomicsresultssummaryofasurveyfromthehesigenomicsstateofsciencesubcommittee AT haymeskenneth currentandfutureapplicationsoftoxicogenomicsresultssummaryofasurveyfromthehesigenomicsstateofsciencesubcommittee AT duvalmanuel currentandfutureapplicationsoftoxicogenomicsresultssummaryofasurveyfromthehesigenomicsstateofsciencesubcommittee AT stevensjames currentandfutureapplicationsoftoxicogenomicsresultssummaryofasurveyfromthehesigenomicsstateofsciencesubcommittee AT afsharicynthia currentandfutureapplicationsoftoxicogenomicsresultssummaryofasurveyfromthehesigenomicsstateofsciencesubcommittee AT vickersalison currentandfutureapplicationsoftoxicogenomicsresultssummaryofasurveyfromthehesigenomicsstateofsciencesubcommittee |